Diallyllysergamide
From Self-sufficiency
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
200px | |
Systematic (IUPAC) name | |
---|---|
(6aR,9R)- N,N- diallyl- 7-methyl- 4,6,6a,7,8,9- hexahydroindolo- [4,3-fg] quinoline- 9- carboxamide | |
Clinical data | |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | hepatic |
Excretion | renal |
Identifiers | |
ATC code | none |
Synonyms | DAL, Lysergic acid diallylamide, d-lysergic acid diallylamide, d-diallyllysergamide |
Chemical data | |
Formula | C22H25N3O |
Molar mass | 349.467 g/mol[[Script error: No such module "String".]] |
Diallyllysergamide (DAL, as the tartrate salt) is a psychedelic lysergamide. In their book TiHKAL, Alexander and Ann Shulgin describe it as being "an order of magnitude less potent than LSD itself".
35px | This drug article relating to the nervous system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Articles lacking sources from December 2009
- Articles with invalid date parameter in template
- All articles lacking sources
- Pages with broken file links
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- 2Fix
- Lysergamides
- Alkenes
- Nervous system drug stubs